Table 2 Characteristics of relapsed patients in SACQ and SQCQ group when they relapsed

Flare

56/170 (32.9%)

29/187 (15.5%)

< 0.001

SLEDAI-2 K

6.0 (4.0, 8.0)

5.0 (2.5, 8.0)

0.036

Recurrence time (month)^a

21.82 (13.39, 31.59)

26.43 (16.72, 41.97)

0.079

Dose of corticosteroids^b (mg)

5.0 (2.81, 7.5)

5.0 (0, 5.0)

0.082

Taking antimalarials

36/56 (64.3%)

17/29 (58.6%)

0.609

Taking immunosuppressants

23/56 (41.1%)

10/29 (34.5%)

0.555